Brian Edwin Cathers, Chief Scientific Officer at Global Blood Therapeutics, Inc. (GBT), sold 2,200 shares at $63.77 ($140K) on 2020-08-20, disclosed to the SEC on 2020-08-24.
Open-market sale of $140k GBT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.